Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04592510
Recruitment Status : Recruiting
First Posted : October 19, 2020
Last Update Posted : June 16, 2021
Sponsor:
Information provided by (Responsible Party):
Fatma Essam El-Deen Abdel Rahim, Cairo University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Assessment of impact of covid-19 on pediatric dental practice during first, second and third wave among a group of pediatric dentists.

Condition or disease
SARS-CoV2

Detailed Description:

On the 11th of March, 2020, COVID-19 (SARS-CoV-2) was declared as a pandemic by the World Health Organization. SARS-CoV-2 is an unpredictable virus that is rapidly transmitting from one country to another, and unfortunately as of today, there is no effective medication or vaccine for the disease control. This virus has gone on to cause one of the most rapidly expanding pandemics with over 9 million people being infected worldwide including the pediatric population.

Due to the unique nature of dentistry, most dental procedures generate significant amounts of droplets and aerosols, posing potential risks of infection transmission. Recent studies have demonstrated the role of the oral mucosa in COVID-19 infection, in addition to expressing the ACE2 receptor in salivary glands in the asymptomatic process in infected saliva, thus being one of the main sources of viruses.

Clinical features of COVID-19 in children include fever and cough, but a large proportion of infected children appears to be asymptomatic and may contribute significantly to transmission. Therefore, it can be assumed that, at this stage in the pandemic, all children and their parents/carers are potentially infective with the potential of cross-infection to dental stuff, parents and the public. This has, in theory, an impact on medical and dental procedures that are Aerosol Generating Procedures.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 345 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave Among a Group of Pediatric Dentists : A Cross -Sectional Study
Actual Study Start Date : May 25, 2021
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : January 2022

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Attitude of pediatric dentists toward treating patients in time of COVID-19. [ Time Frame: 6 months ]
    Measuring device by Questionnaire (Ahmadi, Ebrahimi & Ghorbani, 2020) and (Sinjari et al., 2020). The primary outcome is measured using 5-point likert scale scoring to evaluate pediatric dentists' attitudes


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
Egyptian pediatric dentists regardless of their place of work, in either private clinics or educational hospitals.
Criteria

Inclusion Criteria:

  • Egyptian pediatric dentists with at least Master's degree.
  • Work place located in Egypt.

Exclusion Criteria:

  • Participants who refuse to participate.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04592510


Contacts
Layout table for location contacts
Contact: Fatma Essam El-Deen 01150035515 fatma_essam@dentistry.cu.edu.eg

Locations
Layout table for location information
Egypt
Faculty of Oral and Dental Medicine, Cairo University Recruiting
Cairo, Egypt, 11865
Sponsors and Collaborators
Cairo University
Investigators
Layout table for investigator information
Study Director: Adel El Bardissy Faculty of Oral and dental medicine, Cairo university
Study Chair: Shaimaa Sabry Faculty of Oral and dental medicine, Cairo university
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications:

Layout table for additonal information
Responsible Party: Fatma Essam El-Deen Abdel Rahim, Principal Investigator, Cairo University
ClinicalTrials.gov Identifier: NCT04592510    
Other Study ID Numbers: y66cyyg6
First Posted: October 19, 2020    Key Record Dates
Last Update Posted: June 16, 2021
Last Verified: June 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fatma Essam El-Deen Abdel Rahim, Cairo University:
COVID-19
pediatric dentistry
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases